Supplier News Breaks Archives
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for 2-mg and 4-mg formulations of its Androderm testosterone transdermal system.
Prasco Laboratories has entering a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets in the United States.
The Emerson Group has hired Shane Brown to provide category management insight to its Walmart business team.
Abbott has unveiled plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.
Mylan Inc. announced that its India-based subsidiary, Matrix Laboratories Ltd., has formally changed its name to Mylan Laboratories Ltd.
Bristol-Myers Squibb Co. has announced some executive moves within its senior management team.
Appearing at food festivals nationwide this summer, Scope has rolled out its latest collection of products with its new Dual-Blast technology, which is designed to eliminate strong food odors like onion and garlic while killing bad breath germs.
Prasco Laboratories has been named the exclusive U.S. distributor and pharmaceutical services provider for Aspen Global branded prescription drugs.
The ophthalmic and otic products of Falcon Pharmaceuticals Ltd., the U.S. generics business of Alcon Inc., are being brought under the Sandoz umbrella.
Par Pharmaceutical Cos. has acquired rights to three products from Teva Pharmaceuticals in connection with Teva's acquisition of Cephalon.
Archimedes Pharma Ltd. and its subsidiary, Archimedes Pharma U.S. Inc., have rolled out Lazanda fentanyl nasal spray to U.S. pharmacies.
Kirby Lester has introduced the Kirby Lester 60/30 Combination, a solution that the company bills as packing "a one-two pharmacy automation punch."
Lannett Co. has launched a trio of new generic drug products recently approved by the Food and Drug Administration.
Teva Pharmaceutical Industries Ltd. has closed its acquisition of Cephalon Inc.